| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
3 companies
Bolzon Bradley J Phd is a Director, 10% Owner at GLUE with holdings across 3 companies. Recent SEC Form 4 filings include 4 buys and 3 sells.
Estimated insider holdings value: $50.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 22, 2017 | CRSP Crispr Therapeutics AG | Director | Sell | 26,016 | $20.30 | $528,236.67 | -48.4% | |
| Nov 27, 2017 | CRSP Crispr Therapeutics AG | Director | Sell | 1,707 | $20.21 | $34,498.44 | -1.6% | |
| Oct 24, 2016 | CRSP Crispr Therapeutics AG | Director | Buy | 161,000 | $14.00 | $2,254,000.00 | +2.4% |